FDA issues cannabis research guidelines as CBD industry still hangs in limbo

Mugglehead
By Jared GnamJul 24, 2020, 8:17 pm360 pts
While the U.S. Food and Drug Administration just unveiled new draft guidelines to encourage cannabis-related clinical research, the CBD industry continues to wait in limbo for federal regulations on hemp-based products. On Tuesday, the FDA released a seven-page draft that describes the agency’s “current…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Cannabis Legalization Is a Public Health Necessity 65

Dallas, Texas Pauses Voter-Approved Cannabis Decriminalization Charter 63

Kentucky medical marijuana companies sue, alleging program is unconstitutional 63

A THC Dosage Guide for 1st Time Gummy Consumers 62

New Era of Scaling a Cannabis Business Starts With Discipline, CEO Explains 62

Nearly 4 In 10 Californians Are Current Marijuana Users—And Most Report Health Benefits, Study Shows 62

5 Ways Dispensaries Can Build Momentum Around 7/10 61

Massachusetts Suspends Cannabis Testing Lab’s License; Lawsuit Filed in Appeal 61

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.